State Street Corp Biomarin Pharmaceutical Inc Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, State Street Corp holds 8,823,114 shares of BMRN stock, worth $588 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

8,823,114

Previous 9,636,020 8.44%

Holding current value

$588 Million

Previous $793 Million 21.83%

% of portfolio

0.03%

Previous 0.04%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$69.02 - $93.84 $56.1 Million - $76.3 Million	-812,906 Reduced 8.44%	8,823,114 $620 Million
Q2 2024 Aug 14, 2024	BUY	$74.43 - $92.22 $204 Million - $253 Million	2,740,805 Added 39.75%	9,636,020 $793 Million
Q1 2024 May 15, 2024	BUY	$83.81 - $99.0 $13.8 Million - $16.3 Million	164,700 Added 2.45%	6,895,215 $602 Million
Q4 2023 Feb 14, 2024	BUY	$76.22 - $98.51 $20.7 Million - $26.8 Million	271,786 Added 4.21%	6,730,515 $649 Million
Q3 2023 Nov 14, 2023	BUY	$85.07 - $94.48 $43 Million - $47.7 Million	505,045 Added 8.48%	6,458,729 $571 Million
Q2 2023 Aug 14, 2023	SELL	$86.68 - $100.3 $9.76 Million - $11.3 Million	-112,634 Reduced 1.86%	5,953,684 $516 Million
Q1 2023 May 15, 2023	BUY	$87.74 - $117.27 $59.4 Million - $79.4 Million	677,474 Added 12.57%	6,066,318 $590 Million
Q4 2022 Feb 14, 2023	BUY	$80.93 - $108.63 $8.94 Million - $12 Million	110,406 Added 2.09%	5,388,844 $558 Million
Q3 2022 Nov 15, 2022	SELL	$82.16 - $96.94 $9.69 Million - $11.4 Million	-117,928 Reduced 2.19%	5,278,438 $447 Million
Q2 2022 Aug 15, 2022	BUY	$71.48 - $86.85 $1.14 Million - $1.39 Million	15,973 Added 0.3%	5,396,366 $447 Million
Q1 2022 May 16, 2022	BUY	$74.28 - $92.69 $4.78 Million - $5.96 Million	64,300 Added 1.21%	5,380,393 $415 Million
Q4 2021 Feb 14, 2022	BUY	$71.72 - $91.47 $20 Million - $25.5 Million	278,628 Added 5.53%	5,316,093 $470 Million
Q3 2021 Nov 15, 2021	BUY	$74.77 - $85.47 $9.75 Million - $11.1 Million	130,408 Added 2.66%	5,037,465 $389 Million
Q2 2021 Aug 16, 2021	BUY	$75.51 - $84.79 $17.6 Million - $19.7 Million	232,655 Added 4.98%	4,907,057 $409 Million
Q1 2021 May 17, 2021	SELL	$74.73 - $90.69 $21.3 Million - $25.9 Million	-285,377 Reduced 5.75%	4,674,402 $353 Million
Q4 2020 Feb 16, 2021	BUY	$72.61 - $90.2 $4.94 Million - $6.13 Million	67,978 Added 1.39%	4,959,779 $435 Million
Q3 2020 Nov 10, 2020	SELL	$71.87 - $131.03 $18.3 Million - $33.4 Million	-254,700 Reduced 4.95%	4,891,801 $372 Million
Q2 2020 Aug 14, 2020	SELL	$79.55 - $124.22 $31.3 Million - $48.8 Million	-393,044 Reduced 7.1%	5,146,501 $635 Million
Q1 2020 May 11, 2020	BUY	$71.37 - $96.85 $395 Million - $537 Million	5,539,545 New	5,539,545 $468 Million

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Biomarin Pharmaceutical Inc Transaction History